038070 — Seoulin Bioscience Co Cashflow Statement
0.000.00%
- KR₩72bn
- KR₩48bn
- KR₩90bn
- 49
- 31
- 10
- 16
Annual cashflow statement for Seoulin Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 8,887 | 4,801 | 15,768 | 9,977 | -2,323 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -5,831 | 1,056 | -7,437 | -1,291 | 8,168 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2,612 | -4,156 | -1,343 | -14,059 | -6,201 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 7,321 | 3,684 | 8,918 | -4,356 | 931 |
Capital Expenditures | -708 | -943 | -1,670 | -707 | -974 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,206 | 1,652 | -29,829 | -1,958 | 28,500 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,914 | 709 | -31,499 | -2,665 | 27,526 |
Financing Cash Flow Items | 1,500 | — | — | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,700 | -402 | 29,008 | 1,077 | -22,778 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 738 | 3,955 | 6,475 | -5,974 | 5,603 |